<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.4.555">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Translational Bioinformatics for Immunogenomics - 8&nbsp; Specific Drugs</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
  margin-bottom: 0em;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./bioinformatic-best-practices.html" rel="next">
<link href="./delayed-drug-allergy.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script src="site_libs/quarto-contrib/glightbox/glightbox.min.js"></script>
<link href="site_libs/quarto-contrib/glightbox/glightbox.min.css" rel="stylesheet">
<link href="site_libs/quarto-contrib/glightbox/lightbox.css" rel="stylesheet">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-KMNNS24XZ5"></script>

<script type="text/javascript">

window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'G-KMNNS24XZ5', { 'anonymize_ip': true});
</script>
<link href="site_libs/htmltools-fill-0.5.8.1/fill.css" rel="stylesheet">
<script src="site_libs/htmlwidgets-1.6.4/htmlwidgets.js"></script>
<script src="site_libs/plotly-binding-4.10.4/plotly.js"></script>
<script src="site_libs/typedarray-0.1/typedarray.min.js"></script>
<script src="site_libs/jquery-3.5.1/jquery.min.js"></script>
<link href="site_libs/crosstalk-1.2.1/css/crosstalk.min.css" rel="stylesheet">
<script src="site_libs/crosstalk-1.2.1/js/crosstalk.min.js"></script>
<link href="site_libs/plotly-htmlwidgets-css-2.11.1/plotly-htmlwidgets.css" rel="stylesheet">
<script src="site_libs/plotly-main-2.11.1/plotly-latest.min.js"></script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav">
    <div class="container-fluid d-flex">
      <button type="button" class="quarto-btn-toggle btn" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
        <i class="bi bi-layout-text-sidebar-reverse"></i>
      </button>
        <nav class="quarto-page-breadcrumbs" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./drug-allergy.html">Drug Allergy</a></li><li class="breadcrumb-item"><a href="./specific-drugs.html"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Specific Drugs</span></a></li></ol></nav>
        <a class="flex-grow-1" role="button" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">      
        </a>
      <button type="button" class="btn quarto-search-button" aria-label="" onclick="window.quartoOpenSearch();">
        <i class="bi bi-search"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse collapse-horizontal quarto-sidebar-collapse-item sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Translational Bioinformatics for Immunogenomics</a> 
        <div class="sidebar-tools-main">
    <a href="https://github.com/mattkrantz/tb4i/" title="Source Code" class="quarto-navigation-tool px-1" aria-label="Source Code"><i class="bi bi-github"></i></a>
  <a href="" class="quarto-reader-toggle quarto-navigation-tool px-1" onclick="window.quartoToggleReader(); return false;" title="Toggle reader mode">
  <div class="quarto-reader-toggle-btn">
  <i class="bi"></i>
  </div>
</a>
</div>
    </div>
      </div>
        <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Welcome</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./intro.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Introduction</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./hla.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Human Leukocyte Antigens</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./functional-divergence.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Functional Divergence</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./hla-imputation-programs.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">HLA Imputation Programs</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./hla-analysis-programs.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">HLA Analysis Programs</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./kir.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Killer Cell Immunoglobulin-like Receptors</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./kir-imputation-programs.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">KIR Allele Imputation Programs</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./erap.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">ERAP</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-3" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./erap-imputation.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">ERAP Imputation</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./bonus.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Bonus</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./drug-allergy.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Drug Allergy</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-4" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./immediate-drug-allergy.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Immediate Drug Allergy</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./delayed-drug-allergy.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Delayed Drug Allergy</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./specific-drugs.html" class="sidebar-item-text sidebar-link active">
 <span class="menu-text"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Specific Drugs</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./bioinformatic-best-practices.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Bioinformatic Best Practices</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-5" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./reproducible-data-analysis-workflow.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Reproducible Data Analysis Workflow</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./project-organization.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Project Organization</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./file-naming-conventions.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">File Naming Conventions</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./package-managers.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Package Managers</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./version-control-with-git.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Version Control with Git</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./rmarkdown.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">14</span>&nbsp; <span class="chapter-title">Dynamic Document Generation with RMarkdown</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./make.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">15</span>&nbsp; <span class="chapter-title">Dependency Management with Make</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./docker.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">16</span>&nbsp; <span class="chapter-title">Containerization with Docker</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./genotype-imputation.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Genotype Imputation</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./presenting-your-medical-research.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Presenting Your Medical Research</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./on-being-a-physician-scientist.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">On Being a Physician-Scientist</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">References</span></a>
  </div>
</li>
    </ul>
    </div>
</nav>
<div id="quarto-sidebar-glass" class="quarto-sidebar-collapse-item" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item"></div>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#antibiotics" id="toc-antibiotics" class="nav-link active" data-scroll-target="#antibiotics">Antibiotics</a>
  <ul>
  <li><a href="#cephalosporins" id="toc-cephalosporins" class="nav-link" data-scroll-target="#cephalosporins">Cephalosporins</a>
  <ul class="collapse">
  <li><a href="#background" id="toc-background" class="nav-link" data-scroll-target="#background">Background</a></li>
  <li><a href="#skin-testing" id="toc-skin-testing" class="nav-link" data-scroll-target="#skin-testing">Skin Testing</a></li>
  <li><a href="#oral-challenge" id="toc-oral-challenge" class="nav-link" data-scroll-target="#oral-challenge">Oral Challenge</a></li>
  </ul></li>
  <li><a href="#fluoroquinolones" id="toc-fluoroquinolones" class="nav-link" data-scroll-target="#fluoroquinolones">Fluoroquinolones</a></li>
  <li><a href="#macrolides" id="toc-macrolides" class="nav-link" data-scroll-target="#macrolides">Macrolides</a>
  <ul class="collapse">
  <li><a href="#background-1" id="toc-background-1" class="nav-link" data-scroll-target="#background-1">Background</a></li>
  <li><a href="#skin-testing-1" id="toc-skin-testing-1" class="nav-link" data-scroll-target="#skin-testing-1">Skin Testing</a></li>
  <li><a href="#oral-challenge-1" id="toc-oral-challenge-1" class="nav-link" data-scroll-target="#oral-challenge-1">Oral Challenge</a></li>
  </ul></li>
  <li><a href="#penicillins" id="toc-penicillins" class="nav-link" data-scroll-target="#penicillins">Penicillins</a>
  <ul class="collapse">
  <li><a href="#background-2" id="toc-background-2" class="nav-link" data-scroll-target="#background-2">Background</a></li>
  <li><a href="#skin-testing-2" id="toc-skin-testing-2" class="nav-link" data-scroll-target="#skin-testing-2">Skin Testing</a></li>
  </ul></li>
  <li><a href="#sulfa-antibiotics" id="toc-sulfa-antibiotics" class="nav-link" data-scroll-target="#sulfa-antibiotics">Sulfa Antibiotics</a>
  <ul class="collapse">
  <li><a href="#background-3" id="toc-background-3" class="nav-link" data-scroll-target="#background-3">Background</a></li>
  </ul></li>
  <li><a href="#vancomycin" id="toc-vancomycin" class="nav-link" data-scroll-target="#vancomycin">Vancomycin</a></li>
  </ul></li>
  <li><a href="#antiepileptic-drugs" id="toc-antiepileptic-drugs" class="nav-link" data-scroll-target="#antiepileptic-drugs">Antiepileptic Drugs</a>
  <ul>
  <li><a href="#background-4" id="toc-background-4" class="nav-link" data-scroll-target="#background-4">Background</a></li>
  </ul></li>
  <li><a href="#antihistamines" id="toc-antihistamines" class="nav-link" data-scroll-target="#antihistamines">Antihistamines</a>
  <ul>
  <li><a href="#references" id="toc-references" class="nav-link" data-scroll-target="#references">References</a></li>
  </ul></li>
  <li><a href="#buproprion" id="toc-buproprion" class="nav-link" data-scroll-target="#buproprion">Buproprion</a></li>
  <li><a href="#gadolinium-based-contrast-agents" id="toc-gadolinium-based-contrast-agents" class="nav-link" data-scroll-target="#gadolinium-based-contrast-agents">Gadolinium-Based Contrast Agents</a>
  <ul>
  <li><a href="#background-5" id="toc-background-5" class="nav-link" data-scroll-target="#background-5">Background</a></li>
  <li><a href="#references-1" id="toc-references-1" class="nav-link" data-scroll-target="#references-1">References</a></li>
  </ul></li>
  <li><a href="#iron" id="toc-iron" class="nav-link" data-scroll-target="#iron">Iron</a>
  <ul>
  <li><a href="#background-6" id="toc-background-6" class="nav-link" data-scroll-target="#background-6">Background</a></li>
  <li><a href="#immediate-hypersensitivity-reactions" id="toc-immediate-hypersensitivity-reactions" class="nav-link" data-scroll-target="#immediate-hypersensitivity-reactions">Immediate Hypersensitivity Reactions</a></li>
  <li><a href="#minor-infusion-reactions" id="toc-minor-infusion-reactions" class="nav-link" data-scroll-target="#minor-infusion-reactions">Minor Infusion Reactions</a></li>
  <li><a href="#skin-testing-3" id="toc-skin-testing-3" class="nav-link" data-scroll-target="#skin-testing-3">Skin Testing</a></li>
  <li><a href="#management" id="toc-management" class="nav-link" data-scroll-target="#management">Management</a></li>
  <li><a href="#references-2" id="toc-references-2" class="nav-link" data-scroll-target="#references-2">References</a></li>
  </ul></li>
  <li><a href="#latex" id="toc-latex" class="nav-link" data-scroll-target="#latex">Latex</a>
  <ul>
  <li><a href="#background-7" id="toc-background-7" class="nav-link" data-scroll-target="#background-7">Background</a>
  <ul class="collapse">
  <li><a href="#skin-testing-4" id="toc-skin-testing-4" class="nav-link" data-scroll-target="#skin-testing-4">Skin Testing</a></li>
  <li><a href="#specific-ige-testing" id="toc-specific-ige-testing" class="nav-link" data-scroll-target="#specific-ige-testing">Specific IgE Testing</a></li>
  <li><a href="#management-1" id="toc-management-1" class="nav-link" data-scroll-target="#management-1">Management</a></li>
  </ul></li>
  </ul></li>
  <li><a href="#local-anesthetics" id="toc-local-anesthetics" class="nav-link" data-scroll-target="#local-anesthetics">Local Anesthetics</a>
  <ul>
  <li><a href="#background-8" id="toc-background-8" class="nav-link" data-scroll-target="#background-8">Background</a></li>
  <li><a href="#skin-testing-5" id="toc-skin-testing-5" class="nav-link" data-scroll-target="#skin-testing-5">Skin Testing</a></li>
  <li><a href="#management-2" id="toc-management-2" class="nav-link" data-scroll-target="#management-2">Management</a></li>
  </ul></li>
  <li><a href="#nonsteroidal-anti-inflammatory-drugs" id="toc-nonsteroidal-anti-inflammatory-drugs" class="nav-link" data-scroll-target="#nonsteroidal-anti-inflammatory-drugs">Nonsteroidal Anti-Inflammatory Drugs</a>
  <ul>
  <li><a href="#background-9" id="toc-background-9" class="nav-link" data-scroll-target="#background-9">Background</a></li>
  <li><a href="#management-3" id="toc-management-3" class="nav-link" data-scroll-target="#management-3">Management</a></li>
  <li><a href="#oral-challenge-2" id="toc-oral-challenge-2" class="nav-link" data-scroll-target="#oral-challenge-2">Oral Challenge</a></li>
  </ul></li>
  <li><a href="#radiocontrast" id="toc-radiocontrast" class="nav-link" data-scroll-target="#radiocontrast">Radiocontrast</a>
  <ul>
  <li><a href="#background-10" id="toc-background-10" class="nav-link" data-scroll-target="#background-10">Background</a></li>
  <li><a href="#infusion-reactions" id="toc-infusion-reactions" class="nav-link" data-scroll-target="#infusion-reactions">Infusion Reactions</a></li>
  <li><a href="#immediate-hypersensitivity-reactions-1" id="toc-immediate-hypersensitivity-reactions-1" class="nav-link" data-scroll-target="#immediate-hypersensitivity-reactions-1">Immediate Hypersensitivity Reactions</a></li>
  <li><a href="#delayed-hypersensitivity-reactions" id="toc-delayed-hypersensitivity-reactions" class="nav-link" data-scroll-target="#delayed-hypersensitivity-reactions">Delayed Hypersensitivity Reactions</a></li>
  <li><a href="#skin-testing-6" id="toc-skin-testing-6" class="nav-link" data-scroll-target="#skin-testing-6">Skin Testing</a></li>
  <li><a href="#intravenous-challenge" id="toc-intravenous-challenge" class="nav-link" data-scroll-target="#intravenous-challenge">Intravenous Challenge</a></li>
  <li><a href="#management-4" id="toc-management-4" class="nav-link" data-scroll-target="#management-4">Management</a></li>
  </ul></li>
  <li><a href="#topicals" id="toc-topicals" class="nav-link" data-scroll-target="#topicals">Topicals</a>
  <ul>
  <li><a href="#antibiotics-1" id="toc-antibiotics-1" class="nav-link" data-scroll-target="#antibiotics-1">Antibiotics</a></li>
  <li><a href="#anesthetics" id="toc-anesthetics" class="nav-link" data-scroll-target="#anesthetics">Anesthetics</a></li>
  <li><a href="#corticosteroids" id="toc-corticosteroids" class="nav-link" data-scroll-target="#corticosteroids">Corticosteroids</a></li>
  <li><a href="#propylene-glycol" id="toc-propylene-glycol" class="nav-link" data-scroll-target="#propylene-glycol">Propylene Glycol</a></li>
  <li><a href="#eye-drops" id="toc-eye-drops" class="nav-link" data-scroll-target="#eye-drops">Eye Drops</a></li>
  </ul></li>
  <li><a href="#vaccines" id="toc-vaccines" class="nav-link" data-scroll-target="#vaccines">Vaccines</a>
  <ul>
  <li><a href="#background-11" id="toc-background-11" class="nav-link" data-scroll-target="#background-11">Background</a></li>
  <li><a href="#skin-testing-7" id="toc-skin-testing-7" class="nav-link" data-scroll-target="#skin-testing-7">Skin Testing</a></li>
  <li><a href="#management-5" id="toc-management-5" class="nav-link" data-scroll-target="#management-5">Management</a></li>
  </ul></li>
  </ul>
<div class="toc-actions"><ul><li><a href="https://github.com/mattkrantz/tb4i/edit/main/specific-drugs.qmd" class="toc-action"><i class="bi bi-github"></i>Edit this page</a></li><li><a href="https://github.com/mattkrantz/tb4i/issues/new" class="toc-action"><i class="bi empty"></i>Report an issue</a></li></ul></div></nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default"><nav class="quarto-page-breadcrumbs quarto-title-breadcrumbs d-none d-lg-block" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./drug-allergy.html">Drug Allergy</a></li><li class="breadcrumb-item"><a href="./specific-drugs.html"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Specific Drugs</span></a></li></ol></nav>
<div class="quarto-title">
<h1 class="title"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Specific Drugs</span></h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  


</header>


<section id="antibiotics" class="level2">
<h2 class="anchored" data-anchor-id="antibiotics">Antibiotics</h2>
<section id="cephalosporins" class="level3">
<h3 class="anchored" data-anchor-id="cephalosporins">Cephalosporins</h3>
<section id="background" class="level4">
<h4 class="anchored" data-anchor-id="background">Background</h4>
<div id="cephalosporins-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-1-contents" aria-controls="callout-1" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What percent of the total US population reports a cephalopsorin allergy?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-1" class="callout-1-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>In the US, 1.3% to 1.7% of the total population reports a cephalosporin allergy whereas 0.5% of pediatric patients report a cephalosporin allergy <span class="citation" data-cites="chow2024 khan2019">(<a href="references.html#ref-chow2024" role="doc-biblioref">Chow, Brunner, and Khan 2024</a>; <a href="references.html#ref-khan2019" role="doc-biblioref">Khan et al. 2019</a>)</span></p>
</div>
</div>
</div>
<div id="cephalosporins-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-2-contents" aria-controls="callout-2" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the most common drug allergy phenotype associated with cephalosporins?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-2" class="callout-2-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Most reactions to cephalosporins are immediate (74.7%)–characterized by urticaria and/or angioedema–as opposed to delayed–typically non-severe maculopapular exanthem (25.3%).</p>
</div>
</div>
</div>
<div id="cephalosporins-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-3-contents" aria-controls="callout-3" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the chemical structure of cephalosporins?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-3" class="callout-3-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The chemical structure of cephalosporins is a four membered ring fused with a six membered dihydrothiazine ring with R1 and R2 side chains.</p>
</div>
</div>
</div>
<div id="cephalosporins-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-4-contents" aria-controls="callout-4" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the major structural component responsible for cross-reactivity between penicillins and cephalopsorins?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-4" class="callout-4-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The R1 side chain is the major component responsible for the cross-reactivity with penicillins and cephalosporins. Tolerance to cephalosporins can usually but always be predicted on the basis of similarities or differences in R1 side chains.</p>
<p>R2 side is less studied but may have a role. There is some evidence that suggests that the opening of the cephalosporin beta-lactam ring destroys the R2 side chain.</p>
</div>
</div>
</div>
<div id="cephalosporins-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-5-contents" aria-controls="callout-5" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What penicillins share the same R1 side chain as cefazolin?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-5" class="callout-5-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Trick question! None!</p>
</div>
</div>
</div>
<div id="cephalosporins-question-6" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-6-contents" aria-controls="callout-6" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Aztreonam (a monobactam and beta-lactam) can be given without any concerns for cross-reactivity to patients with a cephalosporin allergy except which R1 side chain sharing cephalosporin?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-6" class="callout-6-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Ceftazadime.</p>
</div>
</div>
</div>
<div id="cephalosporins-question-7" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-7-contents" aria-controls="callout-7" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What cephalosporin is the main culprit for serum sickness-like reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-7" class="callout-7-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Cefaclor accounts for up to 80% of serum sickness-like reactions.</p>
</div>
</div>
</div>
<div id="fig-cephalosporins" class="quarto-figure quarto-figure-center quarto-float anchored" data-fig-align="center">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-cephalosporins-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/specific-drugs/fig-cephalosporins.png" class="lightbox" data-glightbox="description: .lightbox-desc-1" data-gallery="quarto-lightbox-gallery-1"><img src="images/specific-drugs/fig-cephalosporins.png" class="img-fluid quarto-figure quarto-figure-center figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-cephalosporins-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;8.1: Select cephalosporin cross-reactivity
</figcaption>
</figure>
</div>
</section>
<section id="skin-testing" class="level4">
<h4 class="anchored" data-anchor-id="skin-testing">Skin Testing</h4>
<p>Lack of commercial products and metabolites for skin testing.</p>
<p>Immediate Index agents: cephalexin (55.5%), ceftriaxone (24.9%), and cefazolin (17.5%)</p>
<p>8.9% of pateints had positive skin tests (cefazolin 50% positives)</p>
<p>Time since index reaction, OR 0.71 (95% CI 0.57 - 0.90) for positive skin test. <span class="citation" data-cites="stone2021">(<a href="references.html#ref-stone2021" role="doc-biblioref">Stone, Trubiano, and Phillips 2021</a>)</span></p>
</section>
<section id="oral-challenge" class="level4">
<h4 class="anchored" data-anchor-id="oral-challenge">Oral Challenge</h4>
<p>100% NPV if reaction &gt; 5 years, isolated urticaria, benign MPE, isolated GI symptoms or other non-allergic and orally administere vs 98.5% NPV (95% CI 95.8%-99.7%) if include IV and PO administered. <span class="citation" data-cites="stone2021">(<a href="references.html#ref-stone2021" role="doc-biblioref">Stone, Trubiano, and Phillips 2021</a>)</span></p>
<p>Cephalexin 250 mg oral challenge with 1.5 hour observation. <span class="citation" data-cites="koo2022">(<a href="references.html#ref-koo2022" role="doc-biblioref">Koo et al. 2022</a>)</span></p>
</section>
</section>
<section id="fluoroquinolones" class="level3">
<h3 class="anchored" data-anchor-id="fluoroquinolones">Fluoroquinolones</h3>
</section>
<section id="macrolides" class="level3">
<h3 class="anchored" data-anchor-id="macrolides">Macrolides</h3>
<section id="background-1" class="level4">
<h4 class="anchored" data-anchor-id="background-1">Background</h4>
<div id="macrolides-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-8-contents" aria-controls="callout-8" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the chemical structure of macrolides?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-8" class="callout-8-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Macrolides are defined by a large lactone ring, which varies from 12 to 16 carbons, with 1 or more attached sugar chains. Eyrthromycin and clarithromycin have 14 carbons in their lactone rings while azithromycin has 15.</p>
</div>
</div>
</div>
<div id="macrolides-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-9-contents" aria-controls="callout-9" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the mechanism of action of macrolides?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-9" class="callout-9-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>As 50S ribosomal subunit inhibitors, macrolides exert their bacteriostatic effect by inhibiting protein synthesis.</p>
</div>
</div>
</div>
<div id="macrolides-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-10-contents" aria-controls="callout-10" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the cross-reactivity pattern macrolide antibiotics?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-10" class="callout-10-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>While not extensively studied, macrolide antibiotics with a different number of carbon atoms in their lactone ring are tolerated by most patients. Macrolide antibiotics are also unlikely to cross-react with macrolide immunosuppressants (e.g., tacrolimus, sirolimus).</p>
</div>
</div>
</div>
<div id="macrolides-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-11-contents" aria-controls="callout-11" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are some infections that use macrolides as first-line therapy?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-11" class="callout-11-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Clarithyromycin is used as part of combination treatment for H. pylori. Azithromycin is a part of the first-line combination therapy for Mycobacterium avium complex.</p>
</div>
</div>
</div>
<div id="macrolides-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-12-contents" aria-controls="callout-12" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What non-hypersensitivity reactions are associated with macrolides?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-12" class="callout-12-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<ol type="1">
<li><p>GI side effects: Because macrolides are also agonists for the motilin receptor–stimulating gastric and small intestine motility–they can cause nausea, vomiting, diarrhea, and abdmoninal cramping. Accordingly, erythromycin can be used as a treatment for gastroparesis.</p></li>
<li><p>Sensorineural ototoxicity (usually transient).</p></li>
<li><p>QT interval prolongation.</p></li>
</ol>
</div>
</div>
</div>
</section>
<section id="skin-testing-1" class="level4">
<h4 class="anchored" data-anchor-id="skin-testing-1">Skin Testing</h4>
<p>Skin testing for macrolide immediate hypersensitivity has not been shown to be reliable.</p>
</section>
<section id="oral-challenge-1" class="level4">
<h4 class="anchored" data-anchor-id="oral-challenge-1">Oral Challenge</h4>
<p>For patients with a history of immediate hypersensitivity reaction to a macrolide, graded azithromycin challenge can be performed, starting with azithromycin 25 mg followed by 1 hour observation then 250 mg followed by 2 hour observation.</p>
<p>For patients with a history of non-severe delayed hypersensitivity reaction to a macrolide, single dose azithromycin 250 mg challenge with 2 hour observation can be performed. Patients should be instructed to report any other delayed symptoms, which may occur up to 24 to 48 hours after the challenge dose.</p>
</section>
</section>
<section id="penicillins" class="level3">
<h3 class="anchored" data-anchor-id="penicillins">Penicillins</h3>
<section id="background-2" class="level4">
<h4 class="anchored" data-anchor-id="background-2">Background</h4>
<div id="penicillins-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-13-contents" aria-controls="callout-13" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What percent of the US population reports an allergy to penicillin?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-13" class="callout-13-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Approximately 10% of the US population reports an allergy to penicillin.</p>
</div>
</div>
</div>
<div id="penicillins-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-14-contents" aria-controls="callout-14" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Of individuals reporting a penicillin allergy, what percent are clinically significant immediate or delayed immune-mediated drug reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-14" class="callout-14-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Less than 5% of these reported penicillin allergies are clinically significant immediate or delayed-immune mediated drug reactions.</p>
<p>Over 95% of patients who do not have a history of serious penicillin allergy are actually tolerant because (1) the most common reported reaction is a benign delayed rash (type IV hypersensitivity reaction) which may or may not recur with subsequent penicillin exposure; (2) IgE-mediated penicillin allergy wanes over time, with 80% of patients becoming tolerant after a decade since their index reaction; and (3) the index reaction may have rather been an intolerance or caused by the underlying infection being treated at the time. <span class="citation" data-cites="shenoy2019">(<a href="references.html#ref-shenoy2019" role="doc-biblioref">Shenoy et al. 2019</a>)</span></p>
</div>
</div>
</div>
<div id="penicillins-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-15-contents" aria-controls="callout-15" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What infections are individuals with a history of penicillin allergy at higher risk of developing due to receiving broad-spectrum antibiotics?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-15" class="callout-15-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Individuals who report a penicillin allergy label are more likely to receive broad-spectrum antibiotics that increase the risk for antimicrobial resistance, including methicillin-resistant <em>Staphylococcus aureus</em> and vancomycin-resistant <em>Enterococcus</em>. In addition, broad-spectrum antibiotics also increase the risk of developing <em>Clostridium difficile</em> infection.</p>
<p>Receipt of non-beta-lactam perioperative prophylaxis has been associated with an increased risk of surgical site infections.</p>
</div>
</div>
</div>
<div id="penicillins-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-16-contents" aria-controls="callout-16" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What infection-related drug interaction is associated with individuals developing a maculopapular rash when receiving an aminopenicillin?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-16" class="callout-16-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Epstein-Barr virus. <span class="citation" data-cites="chovel-sella2013">(<a href="references.html#ref-chovel-sella2013" role="doc-biblioref">Chovel-Sella et al. 2013</a>)</span></p>
</div>
</div>
</div>
<div id="penicillins-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-17-contents" aria-controls="callout-17" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What percent of penicillin administrations result in a reaction that could be consistent with a hypersensitivity reaction, most often a rash, that could also be nonallergic?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-17" class="callout-17-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>About 0.5% to 2.0%</p>
</div>
</div>
</div>
<div id="penicillins-question-6" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-18-contents" aria-controls="callout-18" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Currently the rate of IgE-mediated penicillin allergies is decreasing. What is a potential hypothesis for this trend?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-18" class="callout-18-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Potentially due to the decrease in use of parenteral penicillins in the outpatient setting, where most antibiotic use occurs.</p>
<p><span class="citation" data-cites="macy2009">(<a href="references.html#ref-macy2009" role="doc-biblioref">Macy et al. 2009</a>)</span></p>
<div class="cell">
<div class="cell-output-display">
<div class="plotly html-widget html-fill-item" id="htmlwidget-acafc69a9e8359670b71" style="width:100%;height:464px;"></div>
<script type="application/json" data-for="htmlwidget-acafc69a9e8359670b71">{"x":{"data":[{"x":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"y":[15.4,9.1999999999999993,8,9.5999999999999996,4.0999999999999996,8.6999999999999993,10.800000000000001,8.8000000000000007,4.7000000000000002,4.7999999999999998,4.5,4.0999999999999996,3.3999999999999999],"text":["Year: 1995<br />Percent_Positive: 15.4","Year: 1996<br />Percent_Positive:  9.2","Year: 1997<br />Percent_Positive:  8.0","Year: 1998<br />Percent_Positive:  9.6","Year: 1999<br />Percent_Positive:  4.1","Year: 2000<br />Percent_Positive:  8.7","Year: 2001<br />Percent_Positive: 10.8","Year: 2002<br />Percent_Positive:  8.8","Year: 2003<br />Percent_Positive:  4.7","Year: 2004<br />Percent_Positive:  4.8","Year: 2005<br />Percent_Positive:  4.5","Year: 2006<br />Percent_Positive:  4.1","Year: 2007<br />Percent_Positive:  3.4"],"type":"scatter","mode":"lines+markers","line":{"width":1.8897637795275593,"color":"rgba(0,0,0,1)","dash":"solid"},"hoveron":"points","showlegend":false,"xaxis":"x","yaxis":"y","hoverinfo":"text","marker":{"autocolorscale":false,"color":"rgba(0,0,0,1)","opacity":1,"size":5.6692913385826778,"symbol":"circle","line":{"width":1.8897637795275593,"color":"rgba(0,0,0,1)"}},"frame":null}],"layout":{"margin":{"t":43.762557077625573,"r":7.3059360730593621,"b":40.182648401826498,"l":37.260273972602747},"font":{"color":"rgba(0,0,0,1)","family":"","size":14.611872146118724},"title":{"text":"Percentage of Positive Cases Over Time","font":{"color":"rgba(0,0,0,1)","family":"","size":17.534246575342465},"x":0,"xref":"paper"},"xaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[1994.4000000000001,2007.5999999999999],"tickmode":"array","ticktext":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"tickvals":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"categoryorder":"array","categoryarray":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.6529680365296811,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"","size":11.68949771689498},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176002,"zeroline":false,"anchor":"y","title":{"text":"Year","font":{"color":"rgba(0,0,0,1)","family":"","size":14.611872146118724}},"hoverformat":".2f"},"yaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[2.7999999999999998,16],"tickmode":"array","ticktext":["3","6","9","12","15"],"tickvals":[3,6,9,12,15],"categoryorder":"array","categoryarray":["3","6","9","12","15"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.6529680365296811,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"","size":11.68949771689498},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176002,"zeroline":false,"anchor":"x","title":{"text":"Percent Positive (%)","font":{"color":"rgba(0,0,0,1)","family":"","size":14.611872146118724}},"hoverformat":".2f"},"shapes":[{"type":"rect","fillcolor":null,"line":{"color":null,"width":0,"linetype":[]},"yref":"paper","xref":"paper","x0":0,"x1":1,"y0":0,"y1":1}],"showlegend":false,"legend":{"bgcolor":null,"bordercolor":null,"borderwidth":0,"font":{"color":"rgba(0,0,0,1)","family":"","size":11.68949771689498}},"hovermode":"closest","barmode":"relative"},"config":{"doubleClick":"reset","modeBarButtonsToAdd":["hoverclosest","hovercompare"],"showSendToCloud":false},"source":"A","attrs":{"4df161451d0d":{"x":{},"y":{},"type":"scatter"},"4df176725f":{"x":{},"y":{}}},"cur_data":"4df161451d0d","visdat":{"4df161451d0d":["function (y) ","x"],"4df176725f":["function (y) ","x"]},"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.20000000000000001,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script>
</div>
</div>
</div>
</div>
</div>
</section>
<section id="skin-testing-2" class="level4">
<h4 class="anchored" data-anchor-id="skin-testing-2">Skin Testing</h4>
<div id="penicillins-question-7" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-19-contents" aria-controls="callout-19" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the NPV of penicillin skin testing?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-19" class="callout-19-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The NPV of penicillin skin testing is &gt; 95% when performed with only benzylpenicilloyl polylysine plus penicillin G or with benzylpenicilloyl polylysine plus full panel of minor derterminants.</p>
</div>
</div>
</div>
<table class="caption-top table">
<colgroup>
<col style="width: 27%">
<col style="width: 72%">
</colgroup>
<thead>
<tr class="header">
<th>Reagent</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Benzylpenicilloyl polylysine (PrePen®)</td>
<td><ul>
<li><p>Benzylpenicilloyl is the Major antigenic determinant (what 95% of penicillin degrades into)</p></li>
<li><p>PrePen is benzylpenicilloyl complexed with polylysine to constitute a multivalent skin test reagent.</p></li>
<li><p>Polylysine acts like the carrier for the benzylpenicilloyl hapten in vivo.</p></li>
</ul></td>
</tr>
<tr class="even">
<td>Minor derterminant mixture (MDM)</td>
<td><ul>
<li><p>Penicillin G itself, benzylpenicilloate, benzylpenilloate</p></li>
<li><p>Not commercially available expect in South America and Spain</p></li>
</ul></td>
</tr>
<tr class="odd">
<td>Penicillin G</td>
<td><ul>
<li>Also called benzylpenicillin</li>
</ul></td>
</tr>
<tr class="even">
<td>Ampicillin</td>
<td><ul>
<li>Differs only from penicillin G by the presence of an amino group (-NH<sub>2</sub>)</li>
</ul></td>
</tr>
</tbody>
</table>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Note
</div>
</div>
<div class="callout-body-container callout-body">
<p>Selective IgE-mediated reactions to aminopenicillins are rare in North America (e.g.&nbsp;3-5% in the United States) versus 25-50% of skin test positive patients in Europe.</p>
</div>
</div>
<div id="fig-penicillins" class="quarto-figure quarto-figure-center quarto-float anchored" data-fig-align="center">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-penicillins-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/specific-drugs/fig-penicillins.png" class="lightbox" data-glightbox="description: .lightbox-desc-2" data-gallery="quarto-lightbox-gallery-2"><img src="images/specific-drugs/fig-penicillins.png" class="img-fluid quarto-figure quarto-figure-center figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-penicillins-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;8.2: Benzylpenicillin, ampicillin, and benzylpenicillin polylysine
</figcaption>
</figure>
</div>
<p><strong>References:</strong></p>
<p>Chapter 77 Middleton’s Drug Allergy</p>
</section>
</section>
<section id="sulfa-antibiotics" class="level3">
<h3 class="anchored" data-anchor-id="sulfa-antibiotics">Sulfa Antibiotics</h3>
<section id="background-3" class="level4">
<h4 class="anchored" data-anchor-id="background-3">Background</h4>
<div id="sulfa-antibiotics-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-21-contents" aria-controls="callout-21" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What percent of the total population reports an allergy to sulfa antibiotics?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-21" class="callout-21-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The reported global prevalence of sulfa antibiotic allergy is 3% to 6%. The prevalence is higher is individuals with hematological malignancies (12-40%) and HIV (30-70%) <span class="citation" data-cites="serrano-arias2024">(<a href="references.html#ref-serrano-arias2024" role="doc-biblioref">Serrano-Arias et al. 2024</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-22-contents" aria-controls="callout-22" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the structure of sulfa antibiotics?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-22" class="callout-22-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Sulfa antibiotics–also called sulfonylarylamines–are characterized by the presence of a sulfonamide functional group with two side chains, arylamine (aromatic amine) and an aromatic heterocyclic ring <span class="citation" data-cites="serrano-arias2024">(<a href="references.html#ref-serrano-arias2024" role="doc-biblioref">Serrano-Arias et al. 2024</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-23-contents" aria-controls="callout-23" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Although sulfa antibiotics and non-antiobitic sulfamide both contain a sulfonamide functional group, do they cross-react?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-23" class="callout-23-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>No, they do not cross-react because non-antibiotic sulfonamides lack the same side chains as sulfa antibiotics–aryalmine and aromatic heterocyclic ring <span class="citation" data-cites="serrano-arias2024">(<a href="references.html#ref-serrano-arias2024" role="doc-biblioref">Serrano-Arias et al. 2024</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-24-contents" aria-controls="callout-24" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
For what respiratory, opportunistic infection in immunocompromised patients is trimethoprim-sulfamethoxazole the preferred prophylaxis?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-24" class="callout-24-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Trimethoprim-sulfamethoxazole is the preferred prophylaxis for <em>Pneumocystis jirovecii</em> pneumonia (PJP) because of its greater evidence of efficacy and lower cost compared to alternative prophylaxis, such as atovaquone, dapsone, and aerosolized pentamidine <span class="citation" data-cites="maertens2016">(<a href="references.html#ref-maertens2016" role="doc-biblioref">Maertens et al. 2016</a>)</span>.</p>
<p>Further, compared to alternative PJP prophylaxis, trimethoprim-sulfamethoxazole may also prevent other breakthrough infections such as <em>Nocardia</em>, <em>Toxoplasma</em>, S<em>treptococcus pneumoniae</em>, and <em>Haemophilus</em> species.</p>
<p>A Cochrane review on the efficacy of trimethoprim-sulfamethoxazole for PJP prevention in non-HIV immunocompromised patients found the number needed to treat to prevent one case of PJP is 19 <span class="citation" data-cites="stern2014">(<a href="references.html#ref-stern2014" role="doc-biblioref">Stern et al. 2014</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-25-contents" aria-controls="callout-25" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
For what patient populations is prophylaxis for <em>Pneumocystis jirovecii</em> pneumonia recommended?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-25" class="callout-25-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>When considering <em>Pneumocystis jirovecii</em> pneumonia prophylaxis, the two main patient populations to consider are non-HIV immunocompromised and HIV immunocompromised individuals.</p>
<p>HIV immunocompromised:</p>
<ul>
<li>CD4+ T cell count &lt; 200 cells/µL</li>
</ul>
<p>Non-HIV immunocompromised:</p>
<ul>
<li><p>Solid organ transplant</p></li>
<li><p>Bone marrow transplant</p></li>
<li><p>Prednisone ≥ 20 mg (or equivalent) for more than one month</p></li>
</ul>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-6" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-26-contents" aria-controls="callout-26" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
When and in what patient population was <em>Pneumocystis jirovec</em>ii pneumonia first described?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-26" class="callout-26-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The first cases of <em>Pneumocystis jirovecii</em> pneumonia were described in malnourished children in orphanages in Europe during World War II. When initially described, it was referred to as “interstitial plasma cell pneumonia <span class="citation" data-cites="morris2004">(<a href="references.html#ref-morris2004" role="doc-biblioref">Morris et al. 2004</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-7" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-27-contents" aria-controls="callout-27" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What type of pathogen is <em>Pneumocystis jirovecii</em>?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-27" class="callout-27-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p><em>Pneumocystis jirovecii</em> is a ubiquitous fungus with infection commonly occurring at young age, with near universal positivity to Pneumocystis by two years of age <span class="citation" data-cites="vargas2001">(<a href="references.html#ref-vargas2001" role="doc-biblioref">Vargas et al. 2001</a>)</span>. In immunocompetent individuals, primary infection is largely asymptomatic. In addition, colonization with <em>Pneumocystis jirovecii</em> occurs in more than 50% of the general adult population and is assumed to be due to re-infection (i.e.&nbsp;person-to-person transmission, environmental re-exposures) rather than reactivation <span class="citation" data-cites="gigliotti2012">(<a href="references.html#ref-gigliotti2012" role="doc-biblioref">Gigliotti and Wright 2012</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-8" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-28-contents" aria-controls="callout-28" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Why did the nomenclature human Pneumocystis pneumonia change from <em>Pneumocystis carinii</em> to <em>Pneumocystis jiroveci</em>?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-28" class="callout-28-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>DNA sequencing improved our understanding of Pneumocystis and its different species that are associated with various host organisms. Therefore, <em>Pneumocystis jirovecii</em> describes the species that infects humans while <em>Pneumocystis carinii</em> describes the species that infects rats <span class="citation" data-cites="stringer2002">(<a href="references.html#ref-stringer2002" role="doc-biblioref">Stringer et al. 2002</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-9" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-29-contents" aria-controls="callout-29" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What primary immune deficiency is notably associated with a high risk of <em>Pneumocystis jirovecii</em> pneumonia?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-29" class="callout-29-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Hyper-immunoglobulin M syndromes—the X-linked recessive version caused by defects in CD40L (expressed on the surface of T cells to induce antibody isotype switching in B cells)–is associated with a notably increased risk of <em>Pneumocystis jirovecii</em> pneumonia <span class="citation" data-cites="davies2010">(<a href="references.html#ref-davies2010" role="doc-biblioref">Davies and Thrasher 2010</a>)</span>.</p>
</div>
</div>
</div>
<div id="sulfa-antibiotics-question-10" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-30-contents" aria-controls="callout-30" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Why is trimethoprim-sulfamethoxazole sometimes referred to as “co-trimoxazole?”
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-30" class="callout-30-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Co-trimoxazole is the British Approved Name (BAN) for trimethoprim-sulfamethoxazole. BANs are assigned for both single-drug and combination preparations. The prefix of “co-” is used for denote combination drugs like trimethoprim and sulfamethoxazole. For example, the combination of amoxicillin and clavulanic acid has the BAN “co-amoxiclav.”</p>
</div>
</div>
</div>
<div id="fig-sulfonamides" class="quarto-figure quarto-figure-center quarto-float anchored" data-fig-align="center">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-sulfonamides-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/specific-drugs/fig-sulfonamides.png" class="lightbox" data-glightbox="description: .lightbox-desc-3" data-gallery="quarto-lightbox-gallery-3"><img src="images/specific-drugs/fig-sulfonamides.png" class="img-fluid quarto-figure quarto-figure-center figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-sulfonamides-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;8.3: Sulfonamides and sulfone structures
</figcaption>
</figure>
</div>
</section>
</section>
<section id="vancomycin" class="level3">
<h3 class="anchored" data-anchor-id="vancomycin">Vancomycin</h3>
</section>
</section>
<section id="antiepileptic-drugs" class="level2">
<h2 class="anchored" data-anchor-id="antiepileptic-drugs">Antiepileptic Drugs</h2>
<section id="background-4" class="level3">
<h3 class="anchored" data-anchor-id="background-4">Background</h3>
<div id="antiepileptic-drugs-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-31-contents" aria-controls="callout-31" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
How are antiepileptic drugs (AEDs) broadly categorized?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-31" class="callout-31-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>AEDs can be broadly categorized by their structure: aromatic or non-aromatic.</p>
</div>
</div>
</div>
<div id="antiepileptic-drugs-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-32-contents" aria-controls="callout-32" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What defines an “aromatic” versus a “non-aromatic” AED?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-32" class="callout-32-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Historically, compounds were labeled as aromatic based on their distinctive aromas.</p>
<p>Today, <a href="https://en.wikipedia.org/wiki/Aromatic_compound">aromatic compounds</a> and AEDs are defined by containing a benzene ring or other benzene-like properties.</p>
<p><a href="https://en.wikipedia.org/wiki/Benzene">Benzene</a> has a sweet odor and is found naturally (e.g., crude oil) and produced as an intermediate for use in plastics, resins, nylons, synthetic fibers.</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><a href="images/specific-drugs/fig-benzene.png" class="lightbox" data-glightbox="description: .lightbox-desc-4" data-gallery="quarto-lightbox-gallery-4" title="2D skeletal representation of benzene"><img src="images/specific-drugs/fig-benzene.png" class="img-fluid quarto-figure quarto-figure-center figure-img" width="119" alt="2D skeletal representation of benzene"></a></p>
</figure>
</div>
<figcaption>2D skeletal representation of benzene</figcaption>
</figure>
</div>
</div>
</div>
</div>
<div id="antiepileptic-drugs-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-33-contents" aria-controls="callout-33" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Which class of AEDs are associated with the greatest risk of rash and other cutaneous ADRs?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-33" class="callout-33-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Aromatic AEDs are associated with the greatest occurence of rash and other cutaneous ADRs, including phenytoin, carbamazepine, phenobarbital, lamotrigine, zonisamide, and oxcarbazapine.</p>
<p>In addition, there is greater cross-reactivity amongst aromatic AEDs (40-58%) than non-aromatic AEDs.</p>
<p>Of the AEDs with lower rash risk, most are non-aromatic (e.g.&nbsp;valproate, gabapentin, levetiracetam, pregabalin, vigabatrin, lacosamide, brivaracetam).</p>
</div>
</div>
</div>
<div id="tbl-aeds" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-aeds-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;8.1: Select aromatic and non-aromatic AEDs. Adapted from <span class="citation" data-cites="mani2019">(<a href="references.html#ref-mani2019" role="doc-biblioref">Mani et al. 2019</a>)</span>
</figcaption>
<div aria-describedby="tbl-aeds-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 30%">
<col style="width: 27%">
</colgroup>
<thead>
<tr class="header">
<th>Aromatic AEDs</th>
<th>Non-aromatic AEDs</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><ul>
<li><p>Ethosuximide</p></li>
<li><p>Phenytoin</p></li>
<li><p>Phenobarbital</p></li>
<li><p>Carbamepine</p></li>
<li><p>Oxcarbazepine</p></li>
<li><p>Zonisamide</p></li>
<li><p>Lamotrigine</p></li>
<li><p>Clobazam</p></li>
<li><p>Felbamate</p></li>
<li><p>Primidone</p></li>
<li><p>Eslicarbazepine</p></li>
<li><p>Perampanel</p></li>
<li><p>Cannabidiol</p></li>
</ul></td>
<td><ul>
<li><p>Valproate</p></li>
<li><p>Gabapentin</p></li>
<li><p>Topiramate</p></li>
<li><p>Levetiracetam</p></li>
<li><p>Pregabalin</p></li>
<li><p>Vigabatrin</p></li>
<li><p>Lacosamide</p></li>
<li><p>Brivaracetam</p></li>
</ul></td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<div id="antiepileptic-drugs-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-34-contents" aria-controls="callout-34" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are some risk factors for developing AED-induced rashes?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-34" class="callout-34-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<ul>
<li><p>History of previous AED-related skin reaction</p></li>
<li><p>Female &gt; Male (2:1), though difference does not persist after &gt; age 50 years</p></li>
<li><p>Older age</p></li>
<li><p>Low vitamin D concentrations</p></li>
</ul>
</div>
</div>
</div>
<p><strong>Reference</strong></p>
<p>Mani R, Monteleone C, Schalock PC, Truong T, Zhang XB, Wagner ML. Rashes and other hypersensitivity reactions associated with antiepileptic drugs: A review of current literature. Seizure. 2019 Oct;71:270-278. doi: 10.1016/j.seizure.2019.07.015. Epub 2019 Jul 24. PMID: 31491658.</p>
</section>
</section>
<section id="antihistamines" class="level2">
<h2 class="anchored" data-anchor-id="antihistamines">Antihistamines</h2>
<section id="references" class="level3">
<h3 class="anchored" data-anchor-id="references">References</h3>
<p><span class="citation" data-cites="shakouri2013">(<a href="references.html#ref-shakouri2013" role="doc-biblioref">Shakouri and Bahna 2013</a>)</span></p>
</section>
</section>
<section id="buproprion" class="level2">
<h2 class="anchored" data-anchor-id="buproprion">Buproprion</h2>
</section>
<section id="gadolinium-based-contrast-agents" class="level2">
<h2 class="anchored" data-anchor-id="gadolinium-based-contrast-agents">Gadolinium-Based Contrast Agents</h2>
<section id="background-5" class="level3">
<h3 class="anchored" data-anchor-id="background-5">Background</h3>
<div id="gbca-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-35-contents" aria-controls="callout-35" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Into what three categories can gadolinium-based contrast agents be divided?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-35" class="callout-35-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Gadolinium-based contrast agents (GBCAs) are divided into three categories based on their stability and carrier molecule (also called chelating agent): ionic linear, nonionic linear, and nonionic macrocyclic.</p>
<p>GBCAs consist of the combination of the gadolinium ion to its carrier molecule.</p>
<p>The carrier molecule serves to minimize the toxicity of gadolinium in its free form while preserving its contrast properties.</p>
</div>
</div>
</div>
<div id="gbca-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-36-contents" aria-controls="callout-36" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
When comparing macrocyclic and linear GBCAs, which takes a shorter amount of time for dissociation of “free” gadolinium?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-36" class="callout-36-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>When compared to macrocyclic GBCAs, linear GBCAs have a lower kinetic stability rate, meaning they take a shorter amount for the dissociation of “free” gadolinium.</p>
<p>This is because the macrocyclic form cages the gadolinium ion leading to better protection while the linear form is an open flexible chain with weaker protection.</p>
<p>However, despite their lower stability, linear GBCAs seem to cause less adverse reactions than macrocyclic GBCAs.</p>
</div>
</div>
</div>
<div id="gbca-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-37-contents" aria-controls="callout-37" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Between linear and macrocylclic GBCAs, which seem to cause less adverse reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-37" class="callout-37-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Despite their lower stability, linear GBCAs seem to cause less adverse reactions than macrocyclic GBCAs.</p>
</div>
</div>
</div>
<div id="gbca-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-38-contents" aria-controls="callout-38" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Where is gadolinium found in nature?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-38" class="callout-38-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Gadolinium is a rare earth element—that does not exist in nature in its pure form due to its high reactivity—and can be extracted from minerals such as monazite and bastnaesite.</p>
</div>
</div>
</div>
<div id="gbca-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-39-contents" aria-controls="callout-39" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Which GBCAs are used when imaging of the hepatobiliary tree is needed? (e.g.&nbsp;MRCP) and why?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-39" class="callout-39-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>When imaging of the hepatobiliary tree is needed, tissue-specific GBCAs (e.g.&nbsp;gadoxetate disodium and gadobenate dimeglumine) are used because they are taken up by hepatocytes and later excreted into the biliary system.</p>
</div>
</div>
</div>
<table class="caption-top table">
<colgroup>
<col style="width: 11%">
<col style="width: 58%">
<col style="width: 29%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: center;">Class</th>
<th>Generic Name (Brand Name)</th>
<th style="text-align: center;">Immediate Reactions per 10,000 Administrations</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">Linear, nonionic</td>
<td>Gadodiamide (Omniscan)</td>
<td style="text-align: center;">1.5</td>
</tr>
<tr class="even">
<td style="text-align: center;">Linear, ionic</td>
<td>Gadopentetate (Magnevist), Gadoxetate (Eovist), Gadobenate (MultiHance), Gadofosveset (Ablavar)</td>
<td style="text-align: center;">8.3</td>
</tr>
<tr class="odd">
<td style="text-align: center;">Macrocyclic</td>
<td>Gadobutrol (Gadovist), Gadoterate (Dotarem), Gadoteridol (ProHance)</td>
<td style="text-align: center;">16</td>
</tr>
</tbody>
</table>
</section>
<section id="references-1" class="level3">
<h3 class="anchored" data-anchor-id="references-1">References</h3>
<p><span class="citation" data-cites="chehabeddine2019 behzadi2018">(<a href="references.html#ref-chehabeddine2019" role="doc-biblioref">Chehabeddine et al. 2019</a>; <a href="references.html#ref-behzadi2018" role="doc-biblioref">Behzadi et al. 2018</a>)</span></p>
</section>
</section>
<section id="iron" class="level2">
<h2 class="anchored" data-anchor-id="iron">Iron</h2>
<section id="background-6" class="level3">
<h3 class="anchored" data-anchor-id="background-6">Background</h3>
<div id="iron-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-40-contents" aria-controls="callout-40" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Why is intravenous (IV) iron used?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-40" class="callout-40-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>IV iron is used for the treatment of iron deficiency anemia when oral iron is effective or not tolerated.</p>
</div>
</div>
</div>
<div id="iron-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-42-contents" aria-controls="callout-42" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What IV iron formulations are available in the United States?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-42" class="callout-42-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Formulations available in the United States include low-molecular-weight iron dextran (LWMID), ferric gluconate, iron sucrose, ferumoxytol, iron isomaltoside, and ferric carboxymaltose.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>High-molecular weight iron dextrans were discontinued in the United States due to having a higher rate of hypersensitivity reactions.</p>
</div>
</div>
</div>
</div>
</div>
<div id="tbl-iv-iron" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-iv-iron-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;8.2: Characteristics of iron formulations available in the United States
</figcaption>
<div aria-describedby="tbl-iv-iron-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 23%">
<col style="width: 12%">
<col style="width: 11%">
<col style="width: 6%">
<col style="width: 17%">
<col style="width: 14%">
<col style="width: 10%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: center;">Generic name</th>
<th style="text-align: center;">Iron gluconate</th>
<th style="text-align: center;">Iron Sucrose</th>
<th style="text-align: center;">LMWID</th>
<th style="text-align: center;">Ferric carboxymaltose</th>
<th style="text-align: center;">Iron isomaltoside</th>
<th style="text-align: center;">Ferumoxytol</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">Brand name</td>
<td style="text-align: center;">Ferrlecit</td>
<td style="text-align: center;">Venofer</td>
<td style="text-align: center;">INFeD</td>
<td style="text-align: center;">Injectafer</td>
<td style="text-align: center;">Monofer</td>
<td style="text-align: center;">FeraHeme</td>
</tr>
<tr class="even">
<td style="text-align: center;">Molecular weight (kD)</td>
<td style="text-align: center;">289-440</td>
<td style="text-align: center;">30-60</td>
<td style="text-align: center;">165</td>
<td style="text-align: center;">150</td>
<td style="text-align: center;">150</td>
<td style="text-align: center;">750</td>
</tr>
<tr class="odd">
<td style="text-align: center;">Labile iron (% injected dose)</td>
<td style="text-align: center;">3.3</td>
<td style="text-align: center;">3.5</td>
<td style="text-align: center;">2</td>
<td style="text-align: center;">0.6</td>
<td style="text-align: center;">1</td>
<td style="text-align: center;">0.8</td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
</section>
<section id="immediate-hypersensitivity-reactions" class="level3">
<h3 class="anchored" data-anchor-id="immediate-hypersensitivity-reactions">Immediate Hypersensitivity Reactions</h3>
<div id="iron-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-43-contents" aria-controls="callout-43" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the incidence of anaphylactic reactions with IV iron?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-43" class="callout-43-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Anaphylactic reactions—when high-molecular weight dextrans are excluded—occur with an incidence of &lt; 1 in 200,000.</p>
<p>Significant differences in reaction risk have not been shown among low-molecular weight iron dextran, iron sucrose, ferric gluconate, and ferric carboxymaltose.</p>
</div>
</div>
</div>
<div id="iron-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-44-contents" aria-controls="callout-44" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the mechanism of most IV iron immediate hypersensitivity reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-44" class="callout-44-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Most IV iron immediate hypersensitivity reactions are mediated through complement-activation related pseudoallergy (CARPA). Rarely, hypersensitivity reactions are IgE-mediated.</p>
</div>
</div>
</div>
</section>
<section id="minor-infusion-reactions" class="level3">
<h3 class="anchored" data-anchor-id="minor-infusion-reactions">Minor Infusion Reactions</h3>
<div id="iron-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-45-contents" aria-controls="callout-45" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are the symptoms of minor infusion reactions to IV iron?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-45" class="callout-45-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Symptoms of minor infusion reactions to IV iron include—flushing, chest/back tightness, myalgias—and, importantly, do not have any features of anaphylaxis.</p>
</div>
</div>
</div>
<div id="iron-question-6" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-46-contents" aria-controls="callout-46" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is considered to be the main driver of minor infusion reactions to IV iron?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-46" class="callout-46-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Labile, or also called “free,” iron is associated with minor infusion reactions to IV iron.</p>
</div>
</div>
</div>
</section>
<section id="skin-testing-3" class="level3">
<h3 class="anchored" data-anchor-id="skin-testing-3">Skin Testing</h3>
<div id="iron-question-7" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-47-contents" aria-controls="callout-47" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the utility of immediate skin testing for IV iron hypersensitivity reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-47" class="callout-47-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>As most hypersensitivity reactions are non-IgE-mediated—rather via CARPA—skin testing has limited utility for evaluating IV iron hypersensitivity reactions; however, it may help detect the rare patients with IgE-mediated hypersensitivity.</p>
</div>
</div>
</div>
</section>
<section id="management" class="level3">
<h3 class="anchored" data-anchor-id="management">Management</h3>
<div id="iron-question-8" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-48-contents" aria-controls="callout-48" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are some approaches to subsequent IV iron administration in patients with previous IV iron reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-48" class="callout-48-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Approaches for patients with history of mild to moderate IV iron reactions include: switching to an alternative IV iron formulation, slowing the infusion rate (e.g., 10% of recommended rate during the first 10 to 15 minutes), and/or pre-treatment with non-sedating, second generation antihistamines.</p>
<p>For patients with a history of anaphylactic reactions to IV iron, desensitization can be considered, such as ferric gluconate.</p>
</div>
</div>
</div>
</section>
<section id="references-2" class="level3">
<h3 class="anchored" data-anchor-id="references-2">References</h3>
<p>Gómez-Ramírez S, Shander A, Spahn DR, et al.&nbsp;Prevention and management of acute reactions to intravenous iron in surgical patients. <em>Blood Transfusion</em>. Published online April 10, 2019. doi:<a href="https://doi.org/10.2450/2018.0156-18">10.2450/2018.0156-18</a></p>
<p>Muñoz M, Gómez-Ramírez S, Bhandari S. The safety of available treatment options for iron-deficiency anemia. Expert Opin Drug Saf 2018; 17: 149-59.</p>
</section>
</section>
<section id="latex" class="level2">
<h2 class="anchored" data-anchor-id="latex">Latex</h2>
<section id="background-7" class="level3">
<h3 class="anchored" data-anchor-id="background-7">Background</h3>
<p>NRL = natural rubber latex &gt; 40,000 products with NRL</p>
<p>Hard rubber latex (heat vulcanized at high temp) Less latex antigen (most allergen denatured at high heat) Medical Consumer Gloves, balloons, condoms</p>
<p>Soft rubber latex (dipping process low heat vulcanization; 10-12% latex products made this way) More latex antigen (less allergen denatured at low heat) Bungs, stoppers Medical Consumer rubber car tires</p>
<section id="skin-testing-4" class="level4">
<h4 class="anchored" data-anchor-id="skin-testing-4">Skin Testing</h4>
<dl>
<dt>Standardized latex for skin testing is not available in the US.</dt>
<dd>
<p>95% Sensitivity (false negative can occur with non-standardized extracts), 100% specificity</p>
</dd>
</dl>
</section>
<section id="specific-ige-testing" class="level4">
<h4 class="anchored" data-anchor-id="specific-ige-testing">Specific IgE Testing</h4>
<p>~70-80% sensitivity, 95% specificity</p>
</section>
<section id="management-1" class="level4">
<h4 class="anchored" data-anchor-id="management-1">Management</h4>
<p>In US, medical devices are required to be labelled with warning if contain NRL.</p>
<p>Latex avoidance if subsequent serologic testing negative; however, negative latex IgE susggestive that inadvertant exposure risk is minimal.</p>
</section>
</section>
</section>
<section id="local-anesthetics" class="level2">
<h2 class="anchored" data-anchor-id="local-anesthetics">Local Anesthetics</h2>
<section id="background-8" class="level3">
<h3 class="anchored" data-anchor-id="background-8">Background</h3>
<div id="local-anesthetics-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-49-contents" aria-controls="callout-49" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are the two main groups of local anesthetics (LAs)?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-49" class="callout-49-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Local anesthetics are divided into two groups: ester and amide.</p>
</div>
</div>
</div>
<div id="local-anesthetics-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-50-contents" aria-controls="callout-50" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Is there cross-reactivity between amide and ester LAs?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-50" class="callout-50-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>There is no cross-reactivity between amide and ester LAs.</p>
</div>
</div>
</div>
<div id="local-anesthetics-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-51-contents" aria-controls="callout-51" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the most common adverse reaction phenotype associated with LAs?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-51" class="callout-51-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The most common adverse reaction phenotype associated with LAs are non-allergic, including sympathetic stimulation (pain which can be potentiated by epinephrine if used), systemic toxic effects, and vasovagal syncope.</p>
</div>
</div>
</div>
<div id="local-anesthetics-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-52-contents" aria-controls="callout-52" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Why are amide LAs used more than ester LAs?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-52" class="callout-52-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Amide LAs are used more than ester LAs for several reasons. 1) Amide LAs have longer stability and shelf-life; 2) They are less likely to trigger allergic reactions because unlike ester LAs, they do have a para-aminobenzoic acid (PABA) metabolite which is the main trigger of allergic reactions associated with ester LAs; 3) They are metabolized in the liver whereas ester LAs are broken down by plasma cholinesterase in the blood, leading to variable metabolism and unpredictable pain reduction in individuals and higher potential for systemic toxicity; 4) They have a longer duration of action.</p>
</div>
</div>
</div>
<div id="local-anesthetics-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-53-contents" aria-controls="callout-53" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the most commonly used LA?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-53" class="callout-53-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The most commonly used LA is lidocaine, due to its fast onset of action (2 to 5 min), intermediate duration of action (1 to 2 hours), and relatively low potential for systemic toxicity.</p>
<p>For procedures requiring prolonged anesthesia, bupivicaine is often utilized because of its relatively fast onset (5 to 10 minutes) but much longer duration (several hours). Therefore, bupivicaine is used for epidural anesthesia, spinal anesthesia, and peripheral nerve blocks. Of note, bupivicaine has a higher risk of systemic toxicity compared to lidocaine.</p>
</div>
</div>
</div>
<table class="caption-top table">
<colgroup>
<col style="width: 51%">
<col style="width: 48%">
</colgroup>
<thead>
<tr class="header">
<th>Amides</th>
<th>Esters</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><ul>
<li><p>Bupivacaine (Marcaine, Sensorcaine)</p></li>
<li><p>Lidocaine (Xylocaine)</p></li>
<li><p>Mepivacaine (Carbocaine)</p></li>
</ul></td>
<td><ul>
<li><p>Benzocaine (Americaine, Lanacane)</p></li>
<li><p>Chloroprocaine (Nesacaine)</p></li>
<li><p>Cocaine</p></li>
<li><p>Procaine (Novacaine)</p></li>
<li><p>Tetracaine (Pontocaine)</p></li>
</ul></td>
</tr>
</tbody>
</table>
</section>
<section id="skin-testing-5" class="level3">
<h3 class="anchored" data-anchor-id="skin-testing-5">Skin Testing</h3>
<p>LA preparations without epinephrine should be used for skin testing because the vasoconstricting properties of epineprhine may mask a positive test.</p>
</section>
<section id="management-2" class="level3">
<h3 class="anchored" data-anchor-id="management-2">Management</h3>
<p>If skin testing is negative to lidocaine, a subcutaneous lidocaine 1% with 1.5 mL (15 mg) can be performed followed by a 1.5 hour observation.</p>
</section>
</section>
<section id="nonsteroidal-anti-inflammatory-drugs" class="level2">
<h2 class="anchored" data-anchor-id="nonsteroidal-anti-inflammatory-drugs">Nonsteroidal Anti-Inflammatory Drugs</h2>
<section id="background-9" class="level3">
<h3 class="anchored" data-anchor-id="background-9">Background</h3>
<div id="nsaids-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-54-contents" aria-controls="callout-54" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the prevalence of nonsteroidal anti-inflammatory drug (NSAID) allergy?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-54" class="callout-54-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>In the general population, 1.5 - 3.5% of individuals report an NSAID allergy. However, fewer than 20% of those individuals with self-reported NSAID allergy are consistent with a true hypersensitivity.</p>
</div>
</div>
</div>
<div id="nsaids-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-55-contents" aria-controls="callout-55" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are some important therapeutic uses of NSAIDs?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-55" class="callout-55-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>NSAIDs are important for the treatment of acute coronary syndrome, pain treatment, and for certain high-risk pregnancy conditions.</p>
<p>For individuals with chronic back pain, NSAID allergy is a risk factor for increased receipt of opioid prescriptions and development of opioid use disorder.</p>
</div>
</div>
</div>
</section>
<section id="management-3" class="level3">
<h3 class="anchored" data-anchor-id="management-3">Management</h3>
<p>For non-aspirin exacerbated respiratory disease (AERD) NSAID hypersensitivity, a two-step outpatient NSAID oral challenge has been shown to be a safe and effective approach.</p>
<div id="nsaids-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-56-contents" aria-controls="callout-56" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What factors are associated with a positive NSAID challenge?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-56" class="callout-56-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<ul>
<li><p>NSAID reaction within the past 5 years</p></li>
<li><p>Prior immediate reaction within 3 hours of NSAID ingestion</p></li>
<li><p>History of reaction to multiple NSAIDs</p></li>
<li><p>Presence of co-morbid chronic spontaneous urticaria</p></li>
</ul>
</div>
</div>
</div>
</section>
<section id="oral-challenge-2" class="level3">
<h3 class="anchored" data-anchor-id="oral-challenge-2">Oral Challenge</h3>
<div id="tbl-nsaids" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-nsaids-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;8.3: Proposed two-step protocol for outpatient NSAID oral challenge in patients without AERD. Adapted from <span class="citation" data-cites="li2022">Li et al. (<a href="references.html#ref-li2022" role="doc-biblioref">2022</a>)</span>
</figcaption>
<div aria-describedby="tbl-nsaids-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 22%">
<col style="width: 36%">
<col style="width: 37%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: center;">NSAID</th>
<th style="text-align: center;"><p>Step 1 Dose</p>
<p>(60 minute observation)</p></th>
<th style="text-align: center;"><p>Step 2 Dose</p>
<p>(120 minute observation)</p></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">Aspirin</td>
<td style="text-align: center;">40.5 mg</td>
<td style="text-align: center;">325 mg</td>
</tr>
<tr class="even">
<td style="text-align: center;">Ibuprofen</td>
<td style="text-align: center;">50 mg</td>
<td style="text-align: center;">500 mg</td>
</tr>
<tr class="odd">
<td style="text-align: center;">Naproxen</td>
<td style="text-align: center;">60 mg</td>
<td style="text-align: center;">600 mg</td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<p>Because of the potential future need for higher dose of aspirin for management of acute coronary syndrome, the second dose for aspirin oral challenge is 325 mg instead of 81 mg.</p>
<p>Of the 262 NSAID challenges performed, over 85% had negative challenges. In addition, 76% of patients included in the study reported a history of urticaria, angioedema, or both <span class="citation" data-cites="li2022">(<a href="references.html#ref-li2022" role="doc-biblioref">Li et al. 2022</a>)</span>. For patients experiencing a positive challenge, 45% had their reaction within 3 hours of NSAID ingestion</p>
</section>
</section>
<section id="radiocontrast" class="level2">
<h2 class="anchored" data-anchor-id="radiocontrast">Radiocontrast</h2>
<section id="background-10" class="level3">
<h3 class="anchored" data-anchor-id="background-10">Background</h3>
<div id="radiocontrast-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-57-contents" aria-controls="callout-57" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
How do modern radiocontrasts differ from older radiocontrasts?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-57" class="callout-57-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Modern radiocontrasts are non-ionic, iodinated and either iso-osmolal or low-osmolality. Older radiocontrasts were high-osmolality–which are no longer used intravenously.</p>
</div>
</div>
</div>
<div id="radiocontrast-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-58-contents" aria-controls="callout-58" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Is radiocontrast allergy related to iodine or seafood allergy?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-58" class="callout-58-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The radiocontrast molecular structure is responsible for hypersensitivity reactions–not iodine or seafood allergy. Shellfish allergy is secondary to tropomyosin not iodine.</p>
</div>
</div>
</div>
</section>
<section id="infusion-reactions" class="level3">
<h3 class="anchored" data-anchor-id="infusion-reactions">Infusion Reactions</h3>
<p>These are also referred to as “toxic” or “chemotoxic” reactions. Characteristic symptoms include transient warmth/flushing, nausea/vomiting, chest pain, metallic taste, hypertension, and/or vasogal signs.</p>
</section>
<section id="immediate-hypersensitivity-reactions-1" class="level3">
<h3 class="anchored" data-anchor-id="immediate-hypersensitivity-reactions-1">Immediate Hypersensitivity Reactions</h3>
<p>The most common immediate hypersensitivity reaction to radiocontrast is mild urticaria and pruritus, occuring in ~0.9% - 3.1% of patients receiving radiocontrast. Anaphylaxis occurs in 0.02% - 0.04% of patients. Of immediate hypersensitivity reactions, 70% occur within 5 minutes of radiocontrast injection and 96% of severe reactions occur within 20 minutes.</p>
</section>
<section id="delayed-hypersensitivity-reactions" class="level3">
<h3 class="anchored" data-anchor-id="delayed-hypersensitivity-reactions">Delayed Hypersensitivity Reactions</h3>
<p>The most common delayed hypersensitivity reaction to radiocontrast is a maculopapular exanthem–occurring in 1 to 3% of patients.</p>
</section>
<section id="skin-testing-6" class="level3">
<h3 class="anchored" data-anchor-id="skin-testing-6">Skin Testing</h3>
<p>Skin prick testing to the culprit and other radiocontrasts followed by intradermal testing–if skin prick testing is negative–can be useful for identifying an alternative radiocontrast agent. A skin test negative radiocontrast alternative has a 95% NPV.</p>
</section>
<section id="intravenous-challenge" class="level3">
<h3 class="anchored" data-anchor-id="intravenous-challenge">Intravenous Challenge</h3>
<p>Intravenous challenge can be performed to radiocontrast with various protocols–such as 1 mL, 5 mL, 15, mL, and 50 mL (cumulative 71 mL) at 60 minute intervals.</p>
</section>
<section id="management-4" class="level3">
<h3 class="anchored" data-anchor-id="management-4">Management</h3>
<p>The culprit radiocontrast should be avoided, and an alternative radiocontrast should be used, guided by negative skin testing if available. Other measures to decrease risk of recurrent radiocontrast reaction include: lowering the radiocontrast dose, decreasing the injection speed, and pre-treatment with non-sedating, second generation antihistamines and/or corticosteroids.</p>
</section>
</section>
<section id="topicals" class="level2">
<h2 class="anchored" data-anchor-id="topicals">Topicals</h2>
<section id="antibiotics-1" class="level3">
<h3 class="anchored" data-anchor-id="antibiotics-1">Antibiotics</h3>
<p>The most common topical antibiotics which cause ACD are those found in triple antibiotic ointment—neomycin, polymyxin B, and bacitracin <span class="citation" data-cites="choi2021">(<a href="references.html#ref-choi2021" role="doc-biblioref">Choi et al. 2021</a>)</span>.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>Of patients with neomycin ACD, 50% will cross-react with other aminoglycosides such as gentamicin.</p>
</div>
</div>
</section>
<section id="anesthetics" class="level3">
<h3 class="anchored" data-anchor-id="anesthetics">Anesthetics</h3>
<p>The most common topical anesthetics which cause ACD are lidocaine and benzocaine.</p>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Note
</div>
</div>
<div class="callout-body-container callout-body">
<p>While patch testing can confirm ACD due to a local anesthetic, not all patients will necessarily develop an allergic reaction to the same anesthetic if used intradermally or subcutaneous—which is often done for dental and dermatologic procedures.</p>
</div>
</div>
</section>
<section id="corticosteroids" class="level3">
<h3 class="anchored" data-anchor-id="corticosteroids">Corticosteroids</h3>
<p>Most patients with ACD secondary to corticosteroids have a history of atopy. Because corticosteroids are often not considered initially as a possible cause of ACD, there might be increased use and worsening of a patient’s dermatitis.</p>
<p>ACD due to corticosteroids may produce an “edge effect” or “doughnut-type” reaction–due to the anti-inflammatory effect of the higher concentration of the corticosteroid in the central area compared to the periphery.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>If a patient has ACD due to a topical corticosteroid, you should consider propylene glycol as a potential cause—an excipient found in various topical corticosteroids and one of the top 4 causes of ACD due to drugs.</p>
</div>
</div>
</section>
<section id="propylene-glycol" class="level3">
<h3 class="anchored" data-anchor-id="propylene-glycol">Propylene Glycol</h3>
<p>Propylene glycol—an excipient—may be utilized in topical drugs as a softening agent, solvent, moisturizer, or preservative.</p>
<p>Of patients with propylene glycol ACD, 80% have a history of atopic dermatitis.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>Propylene glycol is present in various topical emolients, corticosteroids, and calcineurin inhibitors <span class="citation" data-cites="tran2020">(<a href="references.html#ref-tran2020" role="doc-biblioref">Tran and Reeder 2020</a>)</span>.</p>
</div>
</div>
<div id="tbl-topicals-propylene-glycol" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-topicals-propylene-glycol-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;8.4: Select topical drugs for treatment of atopic dermatitis by propylene glcyol content.
</figcaption>
<div aria-describedby="tbl-topicals-propylene-glycol-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<thead>
<tr class="header">
<th>Topical</th>
<th>Propylene glycol-containing</th>
<th>Propylene glycol-free</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Emolients</td>
<td><ul>
<li><a href="https://www.cetaphil.com/us/moisturizers/moisturizing-cream/302993917564.html#productIngredients">Cetaphil Moisturizing Cream</a></li>
</ul></td>
<td><ul>
<li><p><a href="https://www.cerave.com/skincare/moisturizers/moisturizing-cream#product-description">Cerave Moisturizing Cream</a></p></li>
<li><p><a href="https://www.eucerinus.com/products/original/eucerin-original-healing-soothing-repair-creme">Eucerin Orginal Healing Cream</a></p></li>
</ul></td>
</tr>
<tr class="even">
<td>Corticosteroids</td>
<td><ul>
<li>Mometasone furoate ointment 0.1%</li>
</ul></td>
<td><ul>
<li><p>Triamcinolone acetonide ointment 0.1%</p></li>
<li><p>Hydrocortisone ointment 2.5%</p></li>
</ul></td>
</tr>
<tr class="odd">
<td>Calcineurin inhibitors</td>
<td><ul>
<li>Pimecrolimus cream 1%</li>
</ul></td>
<td><ul>
<li>Tacrolimus ointment 0.03% and 0.1%</li>
</ul></td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
</section>
<section id="eye-drops" class="level3">
<h3 class="anchored" data-anchor-id="eye-drops">Eye Drops</h3>
<p>The eyelids are more susceptible to ACD compared to other facial areas—owing to their thin skin 0.55 mm compared to 2 mm, respectively <span class="citation" data-cites="amin2006">(<a href="references.html#ref-amin2006" role="doc-biblioref">Amin and Belsito 2006</a>)</span>. Therefore, the eyelids may be the only affected area by a drug that comes in contact with the face.</p>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Note
</div>
</div>
<div class="callout-body-container callout-body">
<p>ACD due to eye drops is primarily caused by anti-microbial preservatives rather than the primary drug. Benzylalkonium chloride is the most commonly implicated preservative in patients with history of eye drop reactions <span class="citation" data-cites="dear2021">(<a href="references.html#ref-dear2021" role="doc-biblioref">Dear, Palmer, and Nixon 2021</a>)</span>.</p>
</div>
</div>
<div id="tbl-eyedrops-benzalkonium-chloride" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-eyedrops-benzalkonium-chloride-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;8.5: Select commercially-available eye drops for common treatment categories by benzylalkonium chloride content
</figcaption>
<div aria-describedby="tbl-eyedrops-benzalkonium-chloride-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 14%">
<col style="width: 51%">
<col style="width: 33%">
</colgroup>
<thead>
<tr class="header">
<th>Category</th>
<th>Benzyalkonium chloride-containing</th>
<th>Benyzlalkonium chloride-free</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Antibiotic</td>
<td><ul>
<li><p>Ciprofloxacin (Ciloxan)</p></li>
<li><p>Gatifloxacin (Zymar)</p></li>
<li><p>Neomycin/Polymyxin B sulfates/Dexamethasone (Maxitrol)</p></li>
<li><p>Ofloxacin (Ocuflox)</p></li>
<li><p>Polymyxin B sulfate/Trimethoprim (Polytrim)</p></li>
<li><p>Tobramycin (Tobrex)</p></li>
</ul></td>
<td><ul>
<li><p>Moxifloxacin (Vigamox)</p></li>
<li><p>Erythromycin ointment (Ilotycin)</p></li>
</ul></td>
</tr>
<tr class="even">
<td>Corticosteroid</td>
<td><ul>
<li><p>Dexamethasone (Maxidex)</p></li>
<li><p>Prednisolone acetate</p></li>
<li><p>Prednisolone sodium phosphate</p></li>
</ul></td>
<td><ul>
<li>Loteprednol 0.5% ointment</li>
</ul></td>
</tr>
<tr class="odd">
<td>NSAID</td>
<td><ul>
<li><p>Keterolac 0.4% (Acular LS)</p></li>
<li><p>Ketorolac 0.5% (Acular)</p></li>
</ul></td>
<td><ul>
<li>Keterolac 0.45% (Lotemax)</li>
</ul></td>
</tr>
<tr class="even">
<td>Gluacoma</td>
<td><ul>
<li><p>Brinzolamide (Azopt)</p></li>
<li><p>Timolol (Timoptic)</p></li>
</ul></td>
<td><ul>
<li><p>Tafluprost (Zioptan)</p></li>
<li><p>Latanoprost (Iyuzeh)</p></li>
<li><p>Timolol (Timoptic in Ocudose)</p></li>
<li><p>Dorzolamide/Timolol (Cosopt PF)</p></li>
</ul></td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<p>References:</p>
<p><a href="https://eyewiki.org/Preservatives_in_Topical_Ophthalmic_Medications#Benzalkonium_chloride_(BAK)" class="uri">https://eyewiki.org/Preservatives_in_Topical_Ophthalmic_Medications#Benzalkonium_chloride_(BAK)</a></p>
</section>
</section>
<section id="vaccines" class="level2">
<h2 class="anchored" data-anchor-id="vaccines">Vaccines</h2>
<section id="background-11" class="level3">
<h3 class="anchored" data-anchor-id="background-11">Background</h3>
<div id="vaccines-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-64-contents" aria-controls="callout-64" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the reported incidence of any adverse effect after vaccine administration?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-64" class="callout-64-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>It is estimated that any adverse effect from vaccines occurs in 11.4 per 100,000 administrations.</p>
</div>
</div>
</div>
<div id="vaccines-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-65-contents" aria-controls="callout-65" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are the most commonly reported vaccine adverse reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-65" class="callout-65-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The most common vaccine adverse reactions are fever and local injection site reactions–which are not hypersensitivity reactions and are not contraindications to future vaccination.</p>
</div>
</div>
</div>
<div id="vaccines-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-66-contents" aria-controls="callout-66" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the reported incidence of anaphylaxis to vaccines?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-66" class="callout-66-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The reported incidence of anaphylaxis is 1.3 case per million doses.</p>
</div>
</div>
</div>
<div id="vaccines-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-67-contents" aria-controls="callout-67" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Is egg allergy a contraindication to recieiving the influenza vaccine?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-67" class="callout-67-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>No, egg allergy is not a contraindication to receiving the influenza vaccine.</p>
<p>The amount of egg protein (ovalbumin) is not sufficient (&lt; 1 µg) to provoke a reaction even in the recipients with most severe egg allergy.</p>
</div>
</div>
</div>
</section>
<section id="skin-testing-7" class="level3">
<h3 class="anchored" data-anchor-id="skin-testing-7">Skin Testing</h3>
</section>
<section id="management-5" class="level3">
<h3 class="anchored" data-anchor-id="management-5">Management</h3>
<table class="caption-top table">
<colgroup>
<col style="width: 58%">
<col style="width: 11%">
<col style="width: 29%">
</colgroup>
<thead>
<tr class="header">
<th>Reaction Type</th>
<th>Perform Skin Testing?</th>
<th>Vaccine Administration by Skin Testing Result (if applicable)</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Delayed reaction (e.g.&nbsp;late-onset urticaria, local arm swelling)</td>
<td>No</td>
<td>Subsequent dose in usual manner</td>
</tr>
<tr class="even">
<td>Immediate reaction without IgE-mediated reaction features (e.g.&nbsp;tingling, flushing, palpitation, sensation of throat closure)</td>
<td>No</td>
<td>Subsequent dose in usual manner but observe for 30 minutes</td>
</tr>
<tr class="odd">
<td>Immediate reaction with IgE-mediated reaction features (e.g.&nbsp;urticaria, angioedema, wheezing)</td>
<td>Yes</td>
<td><p>Negative: Usual manner 30 min obs</p>
<p>Positive: Split dose</p></td>
</tr>
<tr class="even">
<td>Anaphylaxis</td>
<td>Yes</td>
<td><p>Negative: Split dose</p>
<p>Positive: Graded dose</p></td>
</tr>
</tbody>
</table>
<table class="caption-top table">
<caption>Protocol for vaccine split dose administration</caption>
<colgroup>
<col style="width: 5%">
<col style="width: 38%">
<col style="width: 9%">
<col style="width: 36%">
<col style="width: 8%">
</colgroup>
<thead>
<tr class="header">
<th>Step</th>
<th>Volume (mL) of full-dose full-strength for 0.5 mL vaccine dose</th>
<th>Dilution</th>
<th>Percent of full-dose full-strength for 0.5 mL vaccine dose</th>
<th>Observation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0.05</td>
<td>Full-strength</td>
<td>10%</td>
<td>30 minutes</td>
</tr>
<tr class="even">
<td>2</td>
<td>0.45</td>
<td>Full-strength</td>
<td>90%</td>
<td>30 minutes</td>
</tr>
</tbody>
</table>
<table class="caption-top table">
<caption>Protocol for vaccine graded dose administration</caption>
<colgroup>
<col style="width: 11%">
<col style="width: 14%">
<col style="width: 16%">
<col style="width: 38%">
<col style="width: 14%">
</colgroup>
<thead>
<tr class="header">
<th>Step</th>
<th>Volume (mL)</th>
<th>Dilution</th>
<th>Percent of full-dose full-strength</th>
<th>Observation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0.05</td>
<td>1:10</td>
<td>N/A</td>
<td>15 minutes</td>
</tr>
<tr class="even">
<td>2</td>
<td>0.05</td>
<td>Full-strength</td>
<td>10%</td>
<td>15 minutes</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0.1</td>
<td>Full-strength</td>
<td>20%</td>
<td>15 minutes</td>
</tr>
<tr class="even">
<td>4</td>
<td>0.15</td>
<td>Full-strength</td>
<td>30%</td>
<td>15 minutes</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0.2</td>
<td>Full-strength</td>
<td>40%</td>
<td>15 minutes</td>
</tr>
</tbody>
</table>


<div class="hidden" aria-hidden="true">
<span class="glightbox-desc lightbox-desc-1">Figure&nbsp;8.1: Select cephalosporin cross-reactivity</span>
<span class="glightbox-desc lightbox-desc-2">Figure&nbsp;8.2: Benzylpenicillin, ampicillin, and benzylpenicillin polylysine</span>
<span class="glightbox-desc lightbox-desc-3">Figure&nbsp;8.3: Sulfonamides and sulfone structures</span>
<span class="glightbox-desc lightbox-desc-4">2D skeletal representation of benzene</span>
</div>
<div id="refs" class="references csl-bib-body hanging-indent" data-entry-spacing="0" role="list" style="display: none">
<div id="ref-amin2006" class="csl-entry" role="listitem">
Amin, Kathani A., and Donald V. Belsito. 2006. <span>“The Aetiology of Eyelid Dermatitis: A 10<span>-</span>Year Retrospective Analysis.”</span> <em>Contact Dermatitis</em> 55 (5): 280–85. <a href="https://doi.org/10.1111/j.1600-0536.2006.00927.x">https://doi.org/10.1111/j.1600-0536.2006.00927.x</a>.
</div>
<div id="ref-behzadi2018" class="csl-entry" role="listitem">
Behzadi, Ashkan Heshmatzadeh, Yize Zhao, Zerwa Farooq, and Martin R. Prince. 2018. <span>“Immediate Allergic Reactions to Gadolinium-Based Contrast Agents: A Systematic Review and Meta-Analysis.”</span> <em>Radiology</em> 286 (2): 471–82. <a href="https://doi.org/10.1148/radiol.2017162740">https://doi.org/10.1148/radiol.2017162740</a>.
</div>
<div id="ref-chehabeddine2019" class="csl-entry" role="listitem">
Chehabeddine, Lara, Tala Al Saleh, Marwa Baalbaki, Eman Saleh, Samia J. Khoury, and Salem Hannoun. 2019. <span>“Cumulative Administrations of Gadolinium-Based Contrast Agents: Risks of Accumulation and Toxicity of Linear Vs Macrocyclic Agents.”</span> <em>Critical Reviews in Toxicology</em> 49 (3): 262–79. <a href="https://doi.org/10.1080/10408444.2019.1592109">https://doi.org/10.1080/10408444.2019.1592109</a>.
</div>
<div id="ref-choi2021" class="csl-entry" role="listitem">
Choi, Charles, Saba Vafaei-Nodeh, Jamie Phillips, and Gillian De Gannes. 2021. <span>“Approach to Allergic Contact Dermatitis Caused by Topical Medicaments.”</span> <em>Canadian Family Physician</em> 67 (6): 414–19. <a href="https://doi.org/10.46747/cfp.6706414">https://doi.org/10.46747/cfp.6706414</a>.
</div>
<div id="ref-chovel-sella2013" class="csl-entry" role="listitem">
Chovel-Sella, Aluma, Amir Ben Tov, Einat Lahav, Orna Mor, Hagit Rudich, Gideon Paret, and Shimon Reif. 2013. <span>“Incidence of Rash After Amoxicillin Treatment in Children With Infectious Mononucleosis.”</span> <em>Pediatrics</em> 131 (5): e1424–27. <a href="https://doi.org/10.1542/peds.2012-1575">https://doi.org/10.1542/peds.2012-1575</a>.
</div>
<div id="ref-chow2024" class="csl-entry" role="listitem">
Chow, Timothy G., Elizabeth S. Brunner, and David A. Khan. 2024. <span>“Cephalosporin Allergy: Updates on Diagnostic Testing.”</span> <em>Current Allergy and Asthma Reports</em> 24 (10): 581–90. <a href="https://doi.org/10.1007/s11882-024-01171-9">https://doi.org/10.1007/s11882-024-01171-9</a>.
</div>
<div id="ref-davies2010" class="csl-entry" role="listitem">
Davies, E. Graham, and Adrian J. Thrasher. 2010. <span>“Update on the Hyper Immunoglobulin M Syndromes.”</span> <em>British Journal of Haematology</em> 149 (2): 167–80. <a href="https://doi.org/10.1111/j.1365-2141.2010.08077.x">https://doi.org/10.1111/j.1365-2141.2010.08077.x</a>.
</div>
<div id="ref-dear2021" class="csl-entry" role="listitem">
Dear, Kate, Amanda Palmer, and Rosemary Nixon. 2021. <span>“Contact Allergy and Allergic Contact Dermatitis from Benzalkonium Chloride in a Tertiary Dermatology Center in Melbourne, Australia.”</span> <em>Contact Dermatitis</em> 85 (2): 146–53. <a href="https://doi.org/10.1111/cod.13826">https://doi.org/10.1111/cod.13826</a>.
</div>
<div id="ref-gigliotti2012" class="csl-entry" role="listitem">
Gigliotti, Francis, and Terry W. Wright. 2012. <span>“Pneumocystis: Where Does It Live?”</span> Edited by Joseph Heitman. <em>PLoS Pathogens</em> 8 (11): e1003025. <a href="https://doi.org/10.1371/journal.ppat.1003025">https://doi.org/10.1371/journal.ppat.1003025</a>.
</div>
<div id="ref-khan2019" class="csl-entry" role="listitem">
Khan, David A., Aleena Banerji, Jonathan A. Bernstein, Basar Bilgicer, Kimberly Blumenthal, Mariana Castells, Daniel Ein, David M. Lang, and Elizabeth Phillips. 2019. <span>“Cephalosporin Allergy: Current Understanding and Future Challenges.”</span> <em>The Journal of Allergy and Clinical Immunology: In Practice</em> 7 (7): 2105–14. <a href="https://doi.org/10.1016/j.jaip.2019.06.001">https://doi.org/10.1016/j.jaip.2019.06.001</a>.
</div>
<div id="ref-koo2022" class="csl-entry" role="listitem">
Koo, Grace, Roger Yu, Elizabeth J. Phillips, and Cosby A. Stone. 2022. <span>“Retrospective Stratification of Cephalosporin Allergy Label Risk Using Validated Penicillin Allergy Frameworks.”</span> <em>The Journal of Allergy and Clinical Immunology: In Practice</em> 10 (9): 2472–2475.e1. <a href="https://doi.org/10.1016/j.jaip.2022.05.032">https://doi.org/10.1016/j.jaip.2022.05.032</a>.
</div>
<div id="ref-li2022" class="csl-entry" role="listitem">
Li, Lily, Jillian Bensko, Kathleen Buchheit, Rebecca R. Saff, and Tanya M. Laidlaw. 2022. <span>“Safety, Outcomes, and Recommendations for Two-Step Outpatient Nonsteroidal Anti-Inflammatory Drug Challenges.”</span> <em>The Journal of Allergy and Clinical Immunology: In Practice</em> 10 (5): 1286–1292.e2. <a href="https://doi.org/10.1016/j.jaip.2021.11.006">https://doi.org/10.1016/j.jaip.2021.11.006</a>.
</div>
<div id="ref-macy2009" class="csl-entry" role="listitem">
Macy, Eric, Michael Schatz, Ck Lin, and Kwun-Yee Poon. 2009. <span>“The Falling Rate of Positive Penicillin Skin Tests from 1995 to 2007.”</span> <em>The Permanente Journal</em> 13 (2): 12–18. <a href="https://doi.org/10.7812/TPP/08-073">https://doi.org/10.7812/TPP/08-073</a>.
</div>
<div id="ref-maertens2016" class="csl-entry" role="listitem">
Maertens, Johan, Simone Cesaro, Georg Maschmeyer, Hermann Einsele, J. Peter Donnelly, Alexandre Alanio, Philippe M. Hauser, et al. 2016. <span>“ECIL Guidelines for Preventing Pneumocystis Jirovecii Pneumonia in Patients with Haematological Malignancies and Stem Cell Transplant Recipients.”</span> <em>Journal of Antimicrobial Chemotherapy</em> 71 (9): 2397–2404. <a href="https://doi.org/10.1093/jac/dkw157">https://doi.org/10.1093/jac/dkw157</a>.
</div>
<div id="ref-mani2019" class="csl-entry" role="listitem">
Mani, Ram, Catherine Monteleone, Peter C. Schalock, Thu Truong, Xiao B. Zhang, and Mary L. Wagner. 2019. <span>“Rashes and Other Hypersensitivity Reactions Associated with Antiepileptic Drugs: A Review of Current Literature.”</span> <em>Seizure</em> 71 (October): 270–78. <a href="https://doi.org/10.1016/j.seizure.2019.07.015">https://doi.org/10.1016/j.seizure.2019.07.015</a>.
</div>
<div id="ref-morris2004" class="csl-entry" role="listitem">
Morris, Alison, Jens D. Lundgren, Henry Masur, Peter D. Walzer, Debra L. Hanson, Toni Frederick, Laurence Huang, Charles B. Beard, and Jonathan E. Kaplan. 2004. <span>“Current Epidemiology of <span><em>Pneumocystis</em></span> Pneumonia.”</span> <em>Emerging Infectious Diseases</em> 10 (10): 1713–20. <a href="https://doi.org/10.3201/eid1010.030985">https://doi.org/10.3201/eid1010.030985</a>.
</div>
<div id="ref-serrano-arias2024" class="csl-entry" role="listitem">
Serrano-Arias, Bruno, Adriana Araya-Zúñiga, Johan Waterhouse-Garbanzo, Zoe Rojas-Barrantes, Sebastián Arguedas-Chacón, and Esteban Zavaleta-Monestel. 2024. <span>“A Comprehensive Review of Sulfonamide Hypersensitivity: Implications for Clinical Practice.”</span> <em>Clinical Reviews in Allergy &amp; Immunology</em>, January. <a href="https://doi.org/10.1007/s12016-023-08978-w">https://doi.org/10.1007/s12016-023-08978-w</a>.
</div>
<div id="ref-shakouri2013" class="csl-entry" role="listitem">
Shakouri, Alireza A., and Sami L. Bahna. 2013. <span>“Hypersensitivity to Antihistamines.”</span> <em>Allergy and Asthma Proceedings</em> 34 (6): 488–96. <a href="https://doi.org/10.2500/aap.2013.34.3699">https://doi.org/10.2500/aap.2013.34.3699</a>.
</div>
<div id="ref-shenoy2019" class="csl-entry" role="listitem">
Shenoy, Erica S., Eric Macy, Theresa Rowe, and Kimberly G. Blumenthal. 2019. <span>“Evaluation and Management of Penicillin Allergy: A Review.”</span> <em>JAMA</em> 321 (2): 188. <a href="https://doi.org/10.1001/jama.2018.19283">https://doi.org/10.1001/jama.2018.19283</a>.
</div>
<div id="ref-stern2014" class="csl-entry" role="listitem">
Stern, Anat, Hefziba Green, Mical Paul, Liat Vidal, and Leonard Leibovici. 2014. <span>“Prophylaxis for Pneumocystis Pneumonia (PCP) in Non-HIV Immunocompromised Patients.”</span> Edited by Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group. <em>Cochrane Database of Systematic Reviews</em> 2016 (9). <a href="https://doi.org/10.1002/14651858.CD005590.pub3">https://doi.org/10.1002/14651858.CD005590.pub3</a>.
</div>
<div id="ref-stone2021" class="csl-entry" role="listitem">
Stone, Cosby A., Jason A. Trubiano, and Elizabeth J. Phillips. 2021. <span>“Testing Strategies and Predictors for Evaluating Immediate and Delayed Reactions to Cephalosporins.”</span> <em>The Journal of Allergy and Clinical Immunology: In Practice</em> 9 (1): 435–444.e13. <a href="https://doi.org/10.1016/j.jaip.2020.07.056">https://doi.org/10.1016/j.jaip.2020.07.056</a>.
</div>
<div id="ref-stringer2002" class="csl-entry" role="listitem">
Stringer, James R., Charles B. Beard, Robert F. Miller, and Ann E. Wakefield. 2002. <span>“A new name (Pneumocystis jiroveci) for Pneumocystis from humans.”</span> <em>Emerging Infectious Diseases</em> 8 (9): 891–96. <a href="https://doi.org/10.3201/eid0809.020096">https://doi.org/10.3201/eid0809.020096</a>.
</div>
<div id="ref-tran2020" class="csl-entry" role="listitem">
Tran, Jennifer M., and Margo J. Reeder. 2020. <span>“When the Treatment Is the Culprit: Prevalence of Allergens in Prescription Topical Steroids and Immunomodulators.”</span> <em>Journal of the American Academy of Dermatology</em> 83 (1): 228–30. <a href="https://doi.org/10.1016/j.jaad.2019.11.020">https://doi.org/10.1016/j.jaad.2019.11.020</a>.
</div>
<div id="ref-vargas2001" class="csl-entry" role="listitem">
Vargas, S. L., W. T. Hughes, M. E. Santolaya, A. V. Ulloa, C. A. Ponce, C. E. Cabrera, F. Cumsille, and F. Gigliotti. 2001. <span>“Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants.”</span> <em>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America</em> 32 (6): 855–61. <a href="https://doi.org/10.1086/319340">https://doi.org/10.1086/319340</a>.
</div>
</div>
</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
    var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
    var mailtoRegex = new RegExp(/^mailto:/);
      var filterRegex = new RegExp("https:\/\/tb4i\.mattkrantz\.com\/");
    var isInternal = (href) => {
        return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
    }
    // Inspect non-navigation links and adorn them if external
 	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool)');
    for (var i=0; i<links.length; i++) {
      const link = links[i];
      if (!isInternal(link.href)) {
        // undo the damage that might have been done by quarto-nav.js in the case of
        // links that we want to consider external
        if (link.dataset.originalHref !== undefined) {
          link.href = link.dataset.originalHref;
        }
      }
    }
  function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
    const config = {
      allowHTML: true,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start',
    };
    if (contentFn) {
      config.content = contentFn;
    }
    if (onTriggerFn) {
      config.onTrigger = onTriggerFn;
    }
    if (onUntriggerFn) {
      config.onUntrigger = onUntriggerFn;
    }
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      if (note) {
        return note.innerHTML;
      } else {
        return "";
      }
    });
  }
  const xrefs = window.document.querySelectorAll('a.quarto-xref');
  const processXRef = (id, note) => {
    // Strip column container classes
    const stripColumnClz = (el) => {
      el.classList.remove("page-full", "page-columns");
      if (el.children) {
        for (const child of el.children) {
          stripColumnClz(child);
        }
      }
    }
    stripColumnClz(note)
    if (id === null || id.startsWith('sec-')) {
      // Special case sections, only their first couple elements
      const container = document.createElement("div");
      if (note.children && note.children.length > 2) {
        container.appendChild(note.children[0].cloneNode(true));
        for (let i = 1; i < note.children.length; i++) {
          const child = note.children[i];
          if (child.tagName === "P" && child.innerText === "") {
            continue;
          } else {
            container.appendChild(child.cloneNode(true));
            break;
          }
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(container);
        }
        return container.innerHTML
      } else {
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        return note.innerHTML;
      }
    } else {
      // Remove any anchor links if they are present
      const anchorLink = note.querySelector('a.anchorjs-link');
      if (anchorLink) {
        anchorLink.remove();
      }
      if (window.Quarto?.typesetMath) {
        window.Quarto.typesetMath(note);
      }
      // TODO in 1.5, we should make sure this works without a callout special case
      if (note.classList.contains("callout")) {
        return note.outerHTML;
      } else {
        return note.innerHTML;
      }
    }
  }
  for (var i=0; i<xrefs.length; i++) {
    const xref = xrefs[i];
    tippyHover(xref, undefined, function(instance) {
      instance.disable();
      let url = xref.getAttribute('href');
      let hash = undefined; 
      if (url.startsWith('#')) {
        hash = url;
      } else {
        try { hash = new URL(url).hash; } catch {}
      }
      if (hash) {
        const id = hash.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note !== null) {
          try {
            const html = processXRef(id, note.cloneNode(true));
            instance.setContent(html);
          } finally {
            instance.enable();
            instance.show();
          }
        } else {
          // See if we can fetch this
          fetch(url.split('#')[0])
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.getElementById(id);
            if (note !== null) {
              const html = processXRef(id, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      } else {
        // See if we can fetch a full url (with no hash to target)
        // This is a special case and we should probably do some content thinning / targeting
        fetch(url)
        .then(res => res.text())
        .then(html => {
          const parser = new DOMParser();
          const htmlDoc = parser.parseFromString(html, "text/html");
          const note = htmlDoc.querySelector('main.content');
          if (note !== null) {
            // This should only happen for chapter cross references
            // (since there is no id in the URL)
            // remove the first header
            if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
              note.children[0].remove();
            }
            const html = processXRef(null, note);
            instance.setContent(html);
          } 
        }).finally(() => {
          instance.enable();
          instance.show();
        });
      }
    }, function(instance) {
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            div.style.left = 0;
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
        // Handle positioning of the toggle
    window.addEventListener(
      "resize",
      throttle(() => {
        elRect = undefined;
        if (selectedAnnoteEl) {
          selectCodeLines(selectedAnnoteEl);
        }
      }, 10)
    );
    function throttle(fn, ms) {
    let throttle = false;
    let timer;
      return (...args) => {
        if(!throttle) { // first call gets through
            fn.apply(this, args);
            throttle = true;
        } else { // all the others get throttled
            if(timer) clearTimeout(timer); // cancel #2
            timer = setTimeout(() => {
              fn.apply(this, args);
              timer = throttle = false;
            }, ms);
        }
      };
    }
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./delayed-drug-allergy.html" class="pagination-link" aria-label="Delayed Drug Allergy">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Delayed Drug Allergy</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./bioinformatic-best-practices.html" class="pagination-link" aria-label="Bioinformatic Best Practices">
        <span class="nav-page-text">Bioinformatic Best Practices</span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->
<footer class="footer">
  <div class="nav-footer">
    <div class="nav-footer-left">
<p>Translational Bioinformatics for Immunogenomics was written by Matthew S. Krantz</p>
</div>   
    <div class="nav-footer-center">
      &nbsp;
    <div class="toc-actions d-sm-block d-md-none"><ul><li><a href="https://github.com/mattkrantz/tb4i/edit/main/specific-drugs.qmd" class="toc-action"><i class="bi bi-github"></i>Edit this page</a></li><li><a href="https://github.com/mattkrantz/tb4i/issues/new" class="toc-action"><i class="bi empty"></i>Report an issue</a></li></ul></div></div>
    <div class="nav-footer-right">
<p>This book was built with <a href="https://quarto.org/">Quarto</a>.</p>
</div>
  </div>
</footer>
<script>var lightboxQuarto = GLightbox({"selector":".lightbox","descPosition":"bottom","loop":false,"openEffect":"zoom","closeEffect":"zoom"});
window.onload = () => {
  lightboxQuarto.on('slide_before_load', (data) => {
    const { slideIndex, slideNode, slideConfig, player, trigger } = data;
    const href = trigger.getAttribute('href');
    if (href !== null) {
      const imgEl = window.document.querySelector(`a[href="${href}"] img`);
      if (imgEl !== null) {
        const srcAttr = imgEl.getAttribute("src");
        if (srcAttr && srcAttr.startsWith("data:")) {
          slideConfig.href = srcAttr;
        }
      }
    } 
  });

  lightboxQuarto.on('slide_after_load', (data) => {
    const { slideIndex, slideNode, slideConfig, player, trigger } = data;
    if (window.Quarto?.typesetMath) {
      window.Quarto.typesetMath(slideNode);
    }
  });

};
          </script>




</body></html>